Abstract-Hospital patient outcomes can be improved by the early identification of physiological deterioration. Automatic methods of detecting patient deterioration in vital-sign data typically attempt to identify deviations from assumed "normal" physiological conditions, which is a one-class approach to classification. This paper investigates the use of a two-class approach, in which "abnormal" physiology is modeled explicitly. The success of such a method relies on the accuracy of data labels provided by clinical experts, which may be incomplete (due to large dataset size) or imprecise (due to clinical labels covering intervals, rather than each data point within those intervals). We propose a novel method of refining clinical labels such that the two-class classification approach may be adopted for identifying patient deterioration. We demonstrate the effectiveness of the proposed methods using a large dataset acquired in a 24-bed hospital step-down unit.
I. INTRODUCTION
A DVERSE events during in-hospital patient management are often preceded by physiological deterioration evident in vital-sign data [1] , and it is generally accepted that patient outcomes can be improved by detecting this deterioration sufficiently early [2] . Machine learning techniques have been shown to be able to detect such physiological deterioration by analyzing vital-sign data acquired from bedside monitors connected to acutely ill hospital patients. Recent examples of such approaches include the use of factorial-switched Kalman filters for detecting deterioration in neonatal ICU patients [3] , and Parzen window estimators [4] or Gaussian mixture models [5] , [6] for performing the same function using vital-sign data from adult patients in the acute hospital setting.
A variety of manual methods [7] - [9] have been developed to allow clinicians to identify patient deterioration on the general ward, based on periodically observed vital-sign data, typically acquired every 4-12 h. These so-called early warning score (EWS) systems assign scores based on clinical experience to each vital sign depending on its deviation away from some assumed "normal" range. If any of these scores for a vital sign, or the sum of the scores, exceeds some threshold, then clinical review of the patient is prompted.
Both the manual and automatic methods described previously typically perform novelty detection (or one-class classification), in which deviations from some assumed "normal" behavior are identified. This is a common approach to the condition monitoring of safety-control systems [10] , for which large numbers of examples of "normality" exist, but where there are too few examples of system failure to construct a two-class classifier, in which known failure conditions are explicitly modeled.
However, should sufficient examples of patient deterioration be available, a two-class approach may be adopted. It is assumed a priori that, given sufficient examples of system failure, a twoclass classifier will outperform a one-class classifier due to the inclusion of more information in the classifier [11] . This paper describes an investigation in which a large dataset of patient vital-sign data was acquired during a clinical study. A two-class approach to identifying patient deterioration may be adopted provided that accurate class labels for the data are available. However, typical clinical labels may be incomplete, due to the large size of the datasets (usually clinicians label "abnormal" cases, rather than exhaustively labeling all "normal" cases"). Clinical labels may also be imprecise: clinicians tend to label intervals of patient data, but not each of the data points within those intervals individually; i.e., intervals labeled as "abnormal" may actually contain some "normal" data, and vice versa. We investigate the reliability of class labels provided by clinicians for a large clinical study, and propose novel methods to 1) refine those labels automatically and 2) use the resultant labels in a twoclass classification approach to detecting patient deterioration.
A. Overview
In Section II, we introduce the classification of vital-sign data, and highlight the limitations associated with estimating the classes according to the labels provided by the clinical experts. We demonstrate the classification problems that occur with commonly employed existing methods, including 1) logistic regression; 2) a multilayer perceptron (MLP); 3) a support vector machine (SVM); and 4) a Gaussian Process (GP) classifier. Section III describes our label refinement method to overcome the problems described in Section II. Results are presented in Section IV; conclusions and future work are discussed in Section V.
II. LIMITATIONS OF EXISTING TECHNIQUES

A. Labeling Vital-Sign Data
In order to perform successful classification, accurate labels of "normal" and "abnormal" data are required. In the case of one-class classification (also termed novelty detection), only the former are used for model construction. This can be appropriate if the quantity of "abnormal" data is deemed insufficient to accurately specify the "abnormal" class (or classes), as may occur in the analysis of safety-control systems, such as human patients, for which the quantity of "abnormal" data may be scarce compared with the quantity of "normal" data. Alternatively, if it is deemed that the quantity of "abnormal" data is sufficient, a two-class classification approach may be taken in which both "normal" and "abnormal" data are used, and the "abnormal" class is explicitly modeled.
The success of such methods depends on the accuracy of data labeling, but, for practical clinical datasets, this can be hard to achieve.
1) The quantity of data acquired from continuously monitoring a patient's vital signs is typically so large, when recorded during a study of, for example, several hundred patients, that it is impractical for clinical experts to label data from all patients. In previous studies, clinicians have labeled only those patients for whom known abnormalities occurred in practice [3] , [4] , or only those patients for whom simple univariate alerting criteria [e.g., heart rate ≥ 120 beats/min (bpm)] were identified during retrospective analysis [5] , [6] . 2) Clinical labels are typically applied to intervals in the patient records, rather than to the (continuously acquired) data that fall within those intervals. Thus, a period of "abnormality" may contain examples of "normality" and vice versa. 3) We cannot rely on the use of "hard" patient outcomes (e.g., alive or dead at some time in the future, possibly after discharge) to provide class labels because patients who go on to have a negative outcome (such as an unexpected cardiac arrest, or an unplanned admission to the intensive care unit) could have periods of "normal" physiology, perhaps prior to their deterioration, and similarly periods of "abnormal" physiology prior to complete recovery. The dataset considered in the investigation described in this paper, for example, was 4-D, comprising heart rate (HR), breathing rate (BR), peripheral arterial oxygen saturation (SpO 2 ), and the arithmetic mean of systolic and diastolic blood pressures (the systolic-diastolic average, or SDA). The dataset was acquired from 332 patients in a hospital step-down unit after being in ICU for varied diagnoses, during a three-phase trial conducted at the Presbyterian Hospital, University of Pittsburgh Medical Centre (UPMC), between November, 2006 and August, 2007, and contains over 18 000 h of 4-D vital-sign data [4] . Data were acquired from electronic bedside monitors with a sampling rate of 20 s. All vital-sign measurements including HR, BR, SpO2, and blood pressure were generated by the bedside monitoring devices. The monitors used the ECG channels to estimate HR, and impedance plethysmography (via the ECG electrodes) to estimate BR. The blood pressure was measured noninvasively using an inflatable cuff connected to the bedside monitor. The bedside monitor calculated the systolic and diastolic blood pressures. The arithmetic mean of these two was then calculated to give the SDA. Artifact rejection was carried out by rejecting data outside the following ranges, set by consultation with clinical experts [12] , [13] : HR 30-300 bpm, BR 3-45 r/min, SpO 2 60% and above, SDA 20-180 mmHg. Periods of data with gaps in any one or more of the vital signs were removed by applying a zero-order hold (i.e., by holding values prior to the gap for the duration of the gap).
The approach taken with the dataset considered in this paper was to determine retrospectively which periods of patient data exceeded standard "medical emergency team" (MET) calling criteria [4] . The latter are standard thresholds on each vital sign for triggering an MET call. Periods of patient data that exceeded the MET calling criteria for at least 4 min were shown to a panel of clinicians, who then determined which periods were due to artifact (such as a sensor becoming detached from the patient), and which appeared to be sufficiently abnormal to require MET intervention. We here term the latter class labels of "abnormal" patient condition C 2 , and will refer to examples of "normal" patient condition as having a class label C 1 . Fig. 1 shows the distribution of HR and BR during periods labeled C 2 , and the distribution of each vital sign for patients that had no C 2 periods associated with them (and hence were assumed to be "normal" patients), which we define as being from class C 1 .
It may be seen that the distributions of data from periods labeled C 2 have heavier tails than the distributions of data from "normal" patients, because vital signs tend to take more extreme values during periods of abnormal physiology. However, we note that there is significant overlap between the distributions of data from the two classes. This is because C 2 is not an exhaustive set of all "abnormal" patient condition in the dataset, because clinicians were shown only those periods of data that exceeded MET calling criteria, from which they selected a subset as belonging to class C 2 . Furthermore, a patient typically shows deterioration in fewer than the full number of dimensions, and so some class C 2 data will contain "normal" values for one vital sign even though another vital sign may be highly abnormal at that time. This overlap will cause difficulties for classifiers, as will be shown later in this section.
The figure also shows that some types of physiological abnormality are not represented in the dataset as frequently as other types; e.g., abnormal events involving both or either of apnea (low BR) and bradycardia (low HR) are under-represented in comparison with abnormal events involving both or either of tachypnea (high BR) and tachycardia (high HR). This imbalance will be shown in the remainder of this section to result in standard classification schemes performing poorly when attempting to identify abnormality in patient vital-sign data.
B. Existing One-Class Methods
Much existing work [4] - [9] has used one-class classification to form a model of "normal" physiology, and then detected deviations away from that model and identified them as being "abnormal." A common approach involves forming an estimate of the distribution of vital-sign data f(x|θ), where
are N vectors of vital-sign data in the d-dimensional space defined by the vital signs (e.g., d = 4 when considering the HR, BR, blood pressure, and oxygen saturation levels), and where θ ∈ Θ q are the q parameters defining the probability density function (pdf) f.
For example, the form of f may be constrained to be a mixture of Gaussian distributions. Existing work [4] has defined a threshold on this pdf, f(x|θ) = κ, such that a vector x is classified
An example is shown in Fig. 2 , which shows a training set of "normal" vital-sign data (in gray) and "abnormal" data acquired from patients in our dataset.
In this example, two of the four dimensions of the data, HR and BR, are considered. The four clusters of data plotted in black clearly show the four main modes of physiological abnormality present in this dataset: bradycardia, tachycardia, apnea, and tachypnea. We may also see that the so-called normal data class C 1 extends beyond the central locus of the mass of "normal" data into the regions of data space covered by the physiological abnormalities. This is, as observed previously, because the intervals labeled "abnormal" by clinicians can contain many individually "normal" data points.
The effect of increasing the threshold κ on the pdf f (estimated as described in Section III-A) may be seen in the figure, in which increasing values of κ correspond to larger areas of data space being associated with "normality"; i.e., class C 1 .
The relative prevalence of "normal" data with respect to the two underrepresented (least common) modes of physiology (bradycardia and apnea) causes the approach based on density estimation effectively to misclassify data from these modes. This is shown in the right-most plot of Fig. 2 , where it may be seen that for a large value of threshold κ the data corresponding to bradycardia and apnea (the two clusters of black data in the lower-left quadrant) fall within the white locus of "normal" data, and would thus be incorrectly classified as being "normal." This is highly undesirable for a clinical alerting system, where the priority is on sensitivity to abnormal physiology.
C. Existing Two-Class Methods
As a result of difficulty in acquiring sufficiently large quantities of labeled patient data to adopt a two-class approach, there are very few examples of two-class classification approaches to the problem of patient vital-sign monitoring. However, the large size of the dataset described by this paper may allow the "abnormal" class, C 2 , to be accurately modeled. We note in passing that one could, in the limit, perform two-class classification in which each mode of abnormality is explicitly modeled. However, this would require more data, and would also not scale up to datasets of higher dimensionality; i.e., adding a new vital sign would introduce further modes of abnormality due to the extra vital sign, as well as its possible covariance with modes of abnormality originating from other vital signs. Fig. 3 shows the results of using various two-class classifiers to classify the dataset considered in this paper. We selected a range of classifiers for comparison to demonstrate the effect of our proposed methods across all classification schemes. The classifiers selected cover a range of linear and nonlinear classifiers. All classifiers were trained using tenfold cross validation, and evaluated using previously unseen test data. There were a total of 112 class C 2 events, which corresponds to a total of 1125 4-D data vectors, whereas there were a total of 151 000 4-D data vectors from class C 1 . As there are far fewer class C 2 data than there are class C 1 data, a total of 1215 class C 1 patterns were randomly selected to present balanced training data to the classifier. With a limited total of 2430 patterns to train and test the classification model, setting aside a portion of the data as the test set would reduce the amount of data available for training. To avoid this, a tenfold cross-validation approach was adopted, which removed the need to set aside a separate test set. Fig. 3 shows that the linear decision boundary generated by the logistic regression classifier misclassifies the modes of abnormality caused by bradycardia and apnea, which occur in the lower left quadrant of the figure. The MLP used to obtain the results in Fig. 3 has a single layer of hidden nodes, with an I--J--K architecture, where I is the number of data dimensions (and I = 2 for the bivariate analysis) and J is the number of hidden nodes, and was chosen using cross validation to be J = 3. K = 1 is the number of outputs. While the nonlinear boundary of the MLP provides a better description of "normality" than the linear classifier, it also misclassifies the data from patients with bradycardia and apnea. The SVM used Gaussian kernel functions, where the corresponding bandwidth parameter σ and the SVM "v" parameter used to select the complexity of the decision boundary by penalizing misclassifications [11] were selected via cross validation to be σ = 1 and v = 0.01. The SVM provides a better description of the separation between the "normal" and "abnormal" classes, but still misclassifies a significant proportion of the data from patients with bradycardia and apnea (as may be seen from the circled data in Fig. 3 ). The GP classifier was trained using a squared-exponential covariance function, which is a common choice, akin to the selection of a Gaussian kernel in the SVM, and the Laplace function was used for inference.
III. IMPROVING CLASSIFIER PERFORMANCE USING LABEL REFINEMENT
This section describes a method for improving the performance of a two-class classifier when using the approximate labels provided by clinicians. We will use an initial estimate of the pdf f(x|θ) to constrain the class labels, and then demonstrate that the nonlinear classifiers trained using the modified labels result in better classification of all "abnormal" data.
A. Estimating the pdf
Following [4] , we approximated the pdf f(x|θ) of the vitalsign data using a Parzen window estimator [14] , after reducing the size of the dataset to 400 prototype patterns using k-means clustering with k = 400 cluster centers. The covariance σ 2 of the 400 kernels in the pdf was set using the heuristic proposed in [14] , which typically results in a stable density estimate. Given some data point x, its density κ x = f(x) defines a contour on the pdf. We then define a cumulative distribution function (cdf) F(κ x ) as follows:
where k m = sup{y : y = f (x) ∀x}, the density at the mode of the pdf, f. Thus, F(κ x ) is the probability mass contained by integrating the pdf from its highest density to the probability density contour κ x . This represents the probability that some random data point x distributed according to f will take a density value higher than density value κ x ; i.e., F(κ x ) = Pr[f(x|θ) ≥ κ x ]. Thus, as x varies throughout the data space R d , its probability density will vary over the range [0 κ m ], and thus F(κ x ) will vary over the range [1 0 ] correspondingly, as shown in Fig. 4 .
As a data point x moves from the tails of the pdf to the mode of the pdf, the density κ x = f(x|θ) increases from 0 to its maximum κ m (here κ m ≈ 0.016, as shown in Fig. 4) , and its probability F(κ x ) varies between 1 and 0. Thus, "abnormal" data, which appear in the tails of the pdf, take higher probabilities F(κ x ) than "normal" data, which appear near the mode of the pdf.
B. Thresholding the cdf
We may define some threshold on the cdf, F(κ x ) = T, and consider which data have F(κ x ) ≥ T, for varying values of T. As described previously, we expect data that lie furthest from the mode of the distribution of the whole dataset to take the largest value of F(κ x ), and hence as T is increased, the proportion of data for which F(κ x ) ≥ T will decrease.
This effect can be used to estimate the clinical labels for "abnormal" data; i.e., those from class C 2 . Fig. 5 shows the distribution of BR for data from the dataset for which F(κ x ) ≥ T for different values of T, compared with the distribution of BR from data from class C 2 . It may be seen that as the value of T is increased, the distribution of the data for which F(κ x ) ≥ T (shown by the gray curve) tends toward the distribution of the clinically labeled abnormal data (shown by the black curve). While we have shown in Section II-A that thresholding the pdf (or, equivalently, the cdf as we have described) gives poor classification performance, we could use such a threshold T to aid in refinement of the clinical labels required to train a two-class classifier.
C. Using the cdf to Refine Two-Class Labels
In order to increase the separation between "normal" and "abnormal" data used for training a classifier, and thus better representing the loci of each class, we can refine the C 1 and C 2 class labels provided by clinicians using the following rules: 1) define the training set of "normal" data to be {x ∈ C 1 |F (κ x ) < T, κ x = f (x|θ)}; 2) define the training set of "abnormal" data to be {x ∈ C 2 |F (κ x ) ≥ T, κ x = f (x|θ)} for some "optimal" value of the threshold T, which must be determined.
These rules are based on the prior knowledge of the lowdensity events in the dataset (bradycardia and apnea) which standard one-and two-class classifiers fail to detect, as shown earlier. These rules ensure that the training and test sets contain examples of low-density events, so that these underrepresented events are not ignored in the classifier training.
It now remains to determine the "optimal" value of the threshold T. 75% of the available data from C 2 that obeyed selection criterion "2" were drawn at random from all available data from class C 2 . Then, an equal number of data from class C 1 were drawn at random from all available C 1 data. (This method was used because there are approximately 10 5 more data from the "normal" C 1 class than the "abnormal" C 2 class.) All remaining data from class C 2 were used as test data, and an equal number of data randomly selected from the unused data from class C 1 were used as test data. Fig. 6 shows the misclassification rates obtained when the train-validate-test method was used for an MLP over N = 50 experiments, in which each experiment involved drawing different random training and test sets, using the bivariate data (HR, BR) considered so far in our illustration of the method. The results shown in the figure are those obtained from classifying the (previously unseen) test data, with the classifier architecture selected using tenfold cross validation.
IV. RESULTS
A. Bivariate Data
It may be seen from the figure that as the value of the threshold T is increased from 0 to 1, the number of false-positive misclassifications (i.e., a C 1 data point misclassified as a belonging to C 2 ) decreases while the number of false-negative misclassifications (i.e., a C 2 data point misclassified as a belonging to C 1 ) increases. This is because the "normal" training data (the refined version of class C 1 ) cover a larger locus as T increases. Conversely, the "abnormal" training data (the refined version of class C 2 ) cover a smaller locus as T increases. Thus, the resulting decision boundary of the classifier becomes less sensitive to abnormality with increasing T, because the classifier is trained with an increasingly wider cluster of "normal" data and an increasingly narrower set of clusters of "abnormal" data. Fig. 6 shows that MLP misclassifications are minimized for T ≈ 0.4, which represents the "optimal" value of the threshold T for processing the training data obtained from this dataset. A similar analysis was performed for the SVM, which yielded an "optimal" threshold value of T ≈ 0.5. The same result was obtained using the GP. Fig. 7 shows the results obtained using the "optimal" values of the threshold T. In comparison with results obtained without use of the proposed method (previously shown in Fig. 3) , it may be seen that applying label refinement results in a decision boundary that more effectively separates all four clusters of data corresponding to "abnormal" patient physiology (apnea, tachypnea, bradycardia, and tachycardia) from the larger cluster of data representing "normal" patient physiology, with a corresponding decrease in the number of misclassifications. This better separation of the classes indicates an improvement in the model's ability to discriminate between "normal" and "abnormal" patient data, which is the key aim of the method proposed in this paper. 
B. Multivariate Data
The discussion has so far used bivariate data for the purpose of illustrating the proposed method. In this section, we show results obtained when using the method with the full 4-D dataset. Fig. 8 shows a 2-D projection of the 4-D dataset, obtained by projecting the data onto their first two principal components using principal component analysis (PCA) [11] . Although there is greater overlap in the projection of the 4-D data than was observed for the 2-D data (in Fig. 2 ), the clusters representing the "abnormal" data (shown in black) are similarly distributed around the "normal" data (shown in gray), as was the case with the 2-D data. This similarity in distribution was expected since over 90% of the "abnormal"-labeled events in the database were cardiorespiratory events; i.e., they were related to abnormal HR or BR. Furthermore, some of the overlap may be due to the loss of information from the third and fourth principal components, which have been set to zero for the purposes of visualizing the data in two dimensions. The similarity of the 4-D dataset to the 2-D version considered previously, with both datasets consisting of a central "normal" cluster surrounded by "abnormal" clusters, leads us to conclude that the cdf-based method of refining clinical labels is applicable to refining labels for the full 4-D dataset. Fig. 9 shows the results of optimizing the threshold T for the 4-D dataset, using a two-class SVM to classify the test data selected as described previously, over a series of 50 experiments. As with the bivariate case, a value for the "optimal" threshold was found to be T ≈ 0.5, for which the average number of misclassifications over the 50 experiments was 20 FPs and 21 FNs. Table I presents these results as percentages. Also shown are the FP and FN percentages for classification of the given data with a one-class SVM without the use of the proposed technique, and for a two-class MLP with and without the use of the proposed technique. It may be seen that the one-class classifier results in higher percentages of both FP and FN, than either of the twoclass classifiers. Further, the number of misclassifications is in general lower for the 2-D dataset than for the 4-D dataset, due the increased overlap in four dimensions. Additionally, all three two-class classifiers perform better with the use of the proposed method than without. We have presented a method of 1) refining clinical labels and 2) using the result to train a classifier that better separates "normal" data from "abnormal" data, when compared with the "best-practice" classifiers investigated in this paper that do not use the proposed technique.
This paper has initially presented the results of a bivariate analysis, such that the decision boundaries of classifiers may easily be examined and compared, and then applied a two-class classification method to 4-D data with labels refined using our proposed technique.
We have demonstrated that our proposed method improves the classification performance of the range of classifiers considered, which indicates that existing automated patient monitoring techniques can benefit from using our proposal. For the first time, we have taken a two-class approach to classification, which is of particular relevance to clinical practice: studies in the literature have previously taken a one-class, novelty detection approach because it was deemed that there were insufficient data to construct two-class classifiers. This is a symptom of the difficulty involved in collecting and accurately labeling a large dataset of physiological data in a representative clinical environment. The two-class approach is now valid because we have sufficient representation of "abnormal" modes of physiology in a representative patient cohort to model those modes explicitly. This represents a substantial step forward in the development of "intelligent" patient monitoring systems incorporating prior knowledge of physiology. While we recognize the ultimate need to produce patient-specific approaches to monitoring, initial work must be directly comparable to those methods currently used as the standard of care; hence, we have adopted the population-based approach, which reflects the current practice for both manual systems and existing bedside monitors [15] .
The long-term vision for patient monitoring is a patient-or cohort-specific system, but this requires very large clinical trials in order to acquire sufficient evidence to train various classifiers. With a more limited dataset, we have adopted a two-class approach, in which "normal" and "abnormal" classes are modeled. When sufficient data have been collected, the "abnormal" modes could be divided into more specific models.
External validation of our results is required, although this will require further clinical trials to be performed in other centers. We note that clinical studies [13] have demonstrated that populations of patients in step-down units from hospitals across the U.K. and U.S. have very similar distributions in their vital signs, and this lends support to the general applicability of our method for monitoring such patients.
A further advantage of the proposed method is that, as the value of the threshold T is increased, the distribution of data exceeding that threshold tends toward the distribution of data labeled as belonging to class C 2 by clinicians (see Section III-B).
While there is no substitute for the annotations of clinical experts, it is impractical for a panel of experts to review 18 000 h of continuous data. As described in Section II, the C 2 labels were assigned to a subset of those periods that exceeded univariate MET calling criteria for periods of at least 4 m, and so even those labels are not "gold standard" labels for the entire dataset, being a proxy for the annotation of individual data points (which would be impractical for clinicians to perform).
However, being able to estimate such interval-based labels in an automated manner is useful: the procedure can be applied to further, unlabeled datasets in order to estimate their class C 2 labels. Thus, it may be possible to obtain automatically labeled datasets from large unlabeled datasets.
